RECRUITINGOBSERVATIONAL
The Role of Angiojet Rheolytic Thrombectomy in The Management of Iliofemoral Deep Venous Thrombosis
About This Trial
The aim of this study is to evaluate the efficacy and safety of rheolytic thrombectomy in restoring venous patency DVT, periprocedural complications and development of PTS after tratment of iliofemoral DVT.
Who May Be Eligible (Plain English)
Who May Qualify:
Acute IF DVT
life expectancy more than 1 year
Who Should NOT Join This Trial:
- Recurrence of DVT Chronic DVT The catheter cannot be used in vessels smaller than 6mm. Patients have contraindications for endovascular procedures Patients cannot tolerate contrast media In patients with lesions that cannot be accessed with the guide wire Pregnancy History of pelvic surgery with left iliac vein injury or pelvic radioactive therapy
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
Acute IF DVT
life expectancy more than 1 year
Exclusion Criteria:
* Recurrence of DVT Chronic DVT The catheter cannot be used in vessels smaller than 6mm. Patients have contraindications for endovascular procedures Patients cannot tolerate contrast media In patients with lesions that cannot be accessed with the guide wire Pregnancy History of pelvic surgery with left iliac vein injury or pelvic radioactive therapy
Treatments Being Tested
PROCEDURE
Angiojet Rheolytic Thrombectomy in The Management of Iliofemoral Deep Venous Thrombosis
Angiojet Rheolytic Thrombectomy in The Management of Iliofemoral Deep Venous Thrombosis
Locations (1)
Asyut university
Asyut, Egypt